Is BlackRock a Buy, Sell or Hold
With a large suite of ETF offerings as well as…
Sell
6
APDN Quote, Financials, Valuation and Earnings
Last price:
$0.81
Seasonality move
:
-10.69%
Day range:
$0.77 - $0.83
52-week range:
$0.77 - $376.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.05x
P/B ratio:
0.07x
Volume:
465.1K
Avg. volume:
2.4M
1-year change:
-99.76%
Market cap:
$895.2K
Revenue:
$3.4M
EPS (TTM):
-$285.99
Analysts' Opinion
-
Consensus RatingApplied DNA Sciences has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Applied DNA Sciences has an estimated upside of 184856.84% from its current price of $0.81.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.81.
Fair Value
-
According to the consensus of 1 analyst, Applied DNA Sciences has 184856.84% upside to fair value with a price target of -- per share.
APDN vs. S&P 500
-
Over the past 5 trading days, Applied DNA Sciences has underperformed the S&P 500 by -25.15% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Applied DNA Sciences does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Applied DNA Sciences has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Applied DNA Sciences reported revenues of $1.2M.
Earnings Growth
-
Applied DNA Sciences earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Applied DNA Sciences reported earnings per share of -$28.00.
Enterprise value:
-8.6M
EV / Invested capital:
--
Price / LTM sales:
0.05x
EV / EBIT:
--
EV / Revenue:
-2.30x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
0.62x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.5M
Return On Assets:
-66.06%
Net Income Margin (TTM):
-228.18%
Return On Equity:
-113.07%
Return On Invested Capital:
-113.07%
Operating Margin:
-247.7%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $19.3M | $9M | $3.7M | $891.2K | $1.2M | |
| Gross Profit | $6.3M | $3.4M | $1.5M | $231.1K | $684.1K | |
| Operating Income | -$10.5M | -$13.5M | -$13.2M | -$3.8M | -$3M | |
| EBITDA | -$9.2M | -$12.2M | -$12.7M | -$3.5M | -$2.9M | |
| Diluted EPS | -$650.00 | -$549.00 | -$285.99 | -$86.50 | -$28.00 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.5M | $8.5M | $18.3M | $4.6M | $11.3M | |
| Total Assets | $9.7M | $11.4M | $20.3M | $9.9M | $16M | |
| Current Liabilities | $2.9M | $3M | $3.3M | $2.6M | $2.4M | |
| Total Liabilities | $4M | $3M | $11.1M | $5.8M | $3.4M | |
| Total Equity | $5.7M | $8.4M | $9.2M | $4.1M | $12.5M | |
| Total Debt | $846.8K | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$7.7M | -$7.6M | -$13.3M | -$3.8M | -$3.3M | |
| Cash From Investing | -$339.9K | -$1.1M | -$524.8K | -- | -$116.9K | |
| Cash From Financing | $18.1M | -$35.1K | $19.7M | -$35.1K | $6.3M | |
| Free Cash Flow | -$8M | -$7.7M | -$13.8M | -$3.8M | -$3.4M | |
APDN
Sector
Market Cap
$895.2K
$35M
Price % of 52-Week High
0.22%
42.2%
Dividend Yield
0%
0%
Shareholder Yield
-173.49%
-0.81%
1-Year Price Total Return
-99.76%
-41.61%
Beta (5-Year)
0.856
0.742
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.99
200-day SMA
Sell
Level
$20.79
Bollinger Bands (100)
Sell
Level
3.49 - 10.31
Chaikin Money Flow
Sell
Level
-413.8M
20-day SMA
Sell
Level
$1.45
Relative Strength Index (RSI14)
Sell
Level
19.40
ADX Line
Sell
Level
34.48
Williams %R
Buy
Level
-96.8337
50-day SMA
Sell
Level
$4.44
MACD (12, 26)
Sell
Level
-0.96
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
1.3B
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-35.6681)
Sell
CA Score
(Annual)
Level (-4.9944)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (5.1522)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Stock Forecast FAQ
In the current month, APDN has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The APDN average analyst price target in the past 3 months is --.
-
Where Will Applied DNA Sciences Stock Be In 1 Year?
According to analysts, the consensus estimate is that Applied DNA Sciences share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Applied DNA Sciences?
Analysts are divided on their view about Applied DNA Sciences share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Applied DNA Sciences is a Sell and believe this share price will drop from its current level to --.
-
What Is Applied DNA Sciences's Price Target?
The price target for Applied DNA Sciences over the next 1-year time period is forecast to be -- according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is APDN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Applied DNA Sciences is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of APDN?
You can purchase shares of Applied DNA Sciences via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Applied DNA Sciences shares.
-
What Is The Applied DNA Sciences Share Price Today?
Applied DNA Sciences was last trading at $0.81 per share. This represents the most recent stock quote for Applied DNA Sciences. Yesterday, Applied DNA Sciences closed at $0.81 per share.
-
How To Buy Applied DNA Sciences Stock Online?
In order to purchase Applied DNA Sciences stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Stock a Buy, Sell or Hold?
Uber (NYSE:UBER) has been through quite a ride over the…
Is Micron a Good Stock to Buy Now?
Like most of its peers in the semiconductor industry, Micron…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 32x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
46
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 35x
Alerts
Sell
23
UNH alert for Apr 18
UnitedHealth Group [UNH] is down 22.4% over the past day.
Sell
32
MAN alert for Apr 18
ManpowerGroup [MAN] is down 19.07% over the past day.
Sell
24
GPN alert for Apr 18
Global Payments [GPN] is down 17.44% over the past day.
